The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients
scientific article published on 21 December 2010
Author/s
author: Luis J Leandro-García, Jorge Barriuso, Lucia Inglada, Lucia Inglada-Pérez, Beatriz Martinez-Delgado, Mercedes Robledo, David Hardisson, Cristina Rodríguez-Antona, Andres Redondo Sanchez, Marta Mendiola
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.